Laure Cosson

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

Pierre‐Régis Burgel, I. Durieu, R. Chiron et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 227 citations

Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis

Pierre‐Régis Burgel, À. Munck, I. Durieu et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 127 citations

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription

Elise Dréano, Pierre‐Régis Burgel, Aurélie Hatton et al. · European Respiratory Journal · 2023 · 83 citations

Effect of one-year lumacaftor–ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients

Bastien Misgault, Eva Chatron, Quitterie Reynaud et al. · Journal of Cystic Fibrosis · 2020 · 66 citations · Full text

Glucose Tolerance Abnormalities, One-year Lumacaftor–ivacaftor Treatment, Cystic Fibrosis Patients +3

Barth syndrome in a female patient

Laure Cosson, Annick Toutain, Gilles Simard et al. · Molecular Genetics and Metabolism · 2012 · 56 citations

Connective Tissue Disease, Pathology, Gynecology +4